STEMRON INC has a total of 25 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Australia, Canada and Israel. Its main competitors in its focus markets pharmaceuticals and biotechnology are KURNA INK, CHANGCHUN HUAPU BIOTECHNOLOGY and TAKAKU HIROSHI.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | Canada | 3 | |
#3 | Israel | 3 | |
#4 | New Zealand | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | China | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | United States | 2 | |
#9 | Hong Kong | 1 | |
#10 | Japan | 1 | |
#11 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Yan Wen Liang | 16 |
#2 | Huang Steve Chien-Wen | 12 |
#3 | Lei Jingqi | 10 |
#4 | Khanna Ruchi | 10 |
#5 | Nguyen Minh-Thanh | 9 |
#6 | Lin Hua Helen | 7 |
#7 | Lin Huan | 3 |
#8 | Lin Hua | 2 |
#9 | Huang Steve Chien Wen | 1 |
#10 | Yan Liang Wen | 1 |
Publication | Filing date | Title |
---|---|---|
WO2004003182A2 | Homozygous stem cells isolated from pathogenic oocytes | |
IL163826D0 | Method of constructing a model of cellular development and differentiation using homozygous stem cell systems, methods of assessing | |
IL156746D0 | A method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom and materials and method using same | |
AU2001297880B8 | Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |